Rock Springs Capital Management LP Travere Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 4,973,649 shares of TVTX stock, worth $109 Million. This represents 3.46% of its overall portfolio holdings.
Number of Shares
4,973,649
Previous 4,684,476
6.17%
Holding current value
$109 Million
Previous $65.5 Million
32.2%
% of portfolio
3.46%
Previous 2.23%
Shares
13 transactions
Others Institutions Holding TVTX
# of Institutions
213Shares Held
94.1MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$168 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$162 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$148 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$93.6 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X04.06MShares$89.2 Million0.04% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.41B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...